Search

Search Constraints

You searched for: Author/Creator Ryder, Stephen

Search Results

14. IDDF2018-ABS-0107 Efficacy and safety of TENOFOVIR ALAFENAMIDE (TAF) at 96 weeks in chronic HBV (CHB) patients with risk factors for use of TENOFOVIR DISOPROXIL FUMARATE (TDF). (June 2018)

15. Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. Issue 12 (December 2022)

16. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Issue 10008 (21st November 2015)

17. New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK. Issue 10286 (8th May 2021)

18. New metrics for the Lancet Standing Commission on Liver Disease in the UK. Issue 10083 (20th May 2017)